The European Commission recently approved the pneumococcal vaccine Prevenar 13 (13-valent polysaccharide conjugate vaccine; PCV13) to prevent pneumonia caused by Streptococcus pneumoniae in patients aged 18 years and older. The Joint Committee on Vaccination and Immunisation is reviewing the UK's adult pneumococcal immunisation programme.
Please login or register to read the rest of the article and to have access to downloads and comments.